Litigation concerning the popular antacid medication, Zantac (Ranitidine), is still in the early stages. The FDA announced in September 2019 that the over-the-counter drug contains NDMA – a known human…
When removing a drug from the marketplace, the first step is typically a recall. In order to most effectively protect the public, recalling a potentially harmful or defective product is…
There are several extended-release lots of the type-2 diabetes medication, Metformin, that contain high levels of N-Nitrosodimethylamine (NDMA), a cancer-causing chemical, according to the Food and Drug Administration (FDA). They…
Since September 2019, Zantac and other ranitidine drugs have been undergoing investigation to determine if the levels of N-Nitrosodimethylamine (NDMA) in the medications are above the acceptable safety limit. After…
District Judge Robin L. Rosenberg of the Southern District of Florida had previously set the first status conference for the Zantac MDL (multidistrict litigation) case to be held on March…
A testing lab wants all forms of Zantac heartburn medication recalled after the discovery of unacceptably high levels of N-Nitrosodimethylamine (NDMA) were found in the drug. The dangerous cancer-causing agent…
